Patent ID: 6897230
Filing Date: 2005-05-24
Classification: A61P,C07D

Abstract:
1. A compound of the following formula I: its enantiomer, diastereomer, or pharmaceutically acceptable salt thereof wherein: A represents C (when - - - is present), CH, or N (when - - - is not present); - - - represents a bond; R represents hydrogen, or C R i) hydrogen, ii) NR iii) CR iv) C(═O)R vi) C represents aryl, R R i) NH(C═X ii) NHSO iii) NH(CH iv) NH(CH v) S(CH vi) S(CH vii) O(CH viii) O(CH R i) hydrogen, ii) halogen, iii) C iv) C r and s independently are 1-3, with the provision that when (R R i) hydrogen, ii) C iii) C iv) C v) arylsulfonyl optionally substituted with 1-3 of halogen, C vi) C vii) aminocarbonyl, C viii) five to six membered heterocycles optionally substituted with 1-3 groups of halogen, OH, CN, amino, C ix) C x) benzoyl optionally substituted with 1-3 groups of halogen, OH, C xi) pyrrolylcarbonyl optionally substituted with 1-3 of C xii) C R R i) hydrogen, halogen, OH, C ii) amino, C R i) H, CN, ii) C iii) phenyl optionally substituted with 1-3 groups of halogen, OH, C R X X R R R Each R When two R R R m, n, and q represents 0-1.